Genmark Diagnostics, Inc.
- UEI
- LCHLHA4TDUL3
- CAGE
- 6JBA4
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Expired
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- roche.com
- Founded
- 1896
- Employees
- 100K+
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $131,950 |
| FY2024 | -$301,691 |
| FY2023 | -$613,910 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Diasorin Molecular, LLC | Cypress, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Ortho-Clinical Diagnostics Inc. | — | 334516 Analytical Laboratory Instrument Manufacturing |
| Euroimmun US Incorporated | Mountain Lakes, NJ | 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers |
| Cepheid | Sunnyvale, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Clear Labs Inc. | San Carlos, CA | 621511 Medical Laboratories |
About the company
Genmark Diagnostics, Inc. is a manufacturer of molecular diagnostic testing equipment and supplies. As described on their website, the company produces sample-to-answer systems for infectious disease and genetic testing. Through prime federal contract awards, Genmark Diagnostics provides diagnostic technologies, test kits, reagents, and related services to Department of Veterans Affairs (VA) hospitals and clinics, Department of Defense medical facilities, and the Department of Health and Human Services.
Genmark has delivered molecular testing platforms, assays, and consumables to support genetic screening programs and infectious disease testing at VA and DoD locations across the country. This includes provision of the company's ePlex instrument and Respiratory Pathogen Panel tests to aid in COVID-19 detection efforts. Under contracts with no set-aside designation, Genmark has also supplied reagents, blood typing kits, and maintenance coverage for existing equipment to effectively serve veteran populations. Additionally, the firm was awarded a $749,000 firm fixed price contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to provide its ePlex Respiratory Pathogen Panel in alignment with the agency's broad agency announcement seeking technologies to mitigate lung injury stemming from the COVID-19 pandemic.
Genmark holds several federal contract indefinite delivery vehicles (IDVs) to supply molecular diagnostic equipment and testing supplies to Veterans Health Administration networks and medical centers, with no set-asides applied. A blanket purchase agreement (BPA) with a potential value of $1.15 million facilitates the procurement of Genmark's ePlex analyzers and SARS-CoV-2 test kits to VA locations in Colorado through June 2022. Similarly, a BPA valued at nearly $1.1 million enables the VA to rapidly acquire Genmark's proprietary systems and reagents to support COVID-19 testing activities in Oklahoma through June 2022. Genmark also maintains a five year IDV containing orders for hepatitis C virus genotyping test kits, awarded by VHA Network 23 to aid in serving veterans through next-generation sequencing services.
Quick answers
Is Genmark Diagnostics, Inc. registered in SAM.gov?
Genmark Diagnostics, Inc.'s SAM.gov registration expired on March 23, 2023.
How much has Genmark Diagnostics, Inc. received in federal contracts?
Federal contracts obligated $131,950 to Genmark Diagnostics, Inc. in fiscal year 2025.
How does Genmark Diagnostics, Inc. rank among federal contractors?
Genmark Diagnostics, Inc. ranked #92 in NAICS 325413 in FY2025.
What is Genmark Diagnostics, Inc.'s most recent federal award?
Genmark Diagnostics, Inc.'s most recent federal contract award is Eplex reagents (36C25023P0448), from Veterans Integrated Service Network 10 (VHA), on January 1, 2023.
On GovTribe
See Genmark Diagnostics, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors